Sarepta (SRPT) Wins Key PTO Decision on Composition of Matter Patents - Oppenheimer
Go back to Sarepta (SRPT) Wins Key PTO Decision on Composition of Matter Patents - Oppenheimer| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 82.17 -9.03 (9.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $91.20 | 52 Week High | $108.96 | |||
| Open | $86.26 | 52 Week Low | $62.12 | |||
| Day High | $86.78 | P/E | N/A | |||
| Day Low | $81.00 | EPS | $-1.27 | |||
| Volume | 7,884,453 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 127.39 +3.14 (2.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $124.25 | 52 Week High | $63.73 | |||
| Open | $123.00 | 52 Week Low | $8.00 | |||
| Day High | $130.61 | P/E | N/A | |||
| Day Low | $121.80 | EPS | $-5.69 | |||
| Volume | 1,694,409 | |||||
